Tenax Therapeutics (TENX) Times Interest Earned (2010 - 2026)
Tenax Therapeutics (TENX) reported Times Interest Earned of -$0.24 for Q1 2026, up 100.0% on a YoY basis from -$0.12 in Q1 2025, and up 84.48% sequentially from -$1.53 in Q3 2025.
Tenax Therapeutics (TENX) Times Interest Earned (2010 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 15 years of Times Interest Earned data on file, last reported at -$0.24 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 100.0% year-over-year to -$0.24; the trailing twelve-month figure through Mar 2026 stood at -$0.88 (up 99.99% YoY), and the FY2025 full-year result was -$1.12, down 139.4% from the prior year.
- Times Interest Earned advanced to -$0.24 in Q1 2026, from -$1.53 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $7295.0 in Q4 2024 to a low of -$5939.2 in Q1 2025.
- A 5-year average of -$701.18 and a median of -$1.53 in 2025 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned soared 926.43% in 2023 and sank 1345.49% in 2025, its largest moves.
- Tracing TENX's Times Interest Earned over 5 years: stood at $12.82 in 2022, then plunged by 36036.29% to -$4607.6 in 2023, then jumped by 258.33% to $7295.0 in 2024, then sank by 100.02% to -$1.53 in 2025, then jumped by 84.48% to -$0.24 in 2026.
- Business Quant data shows TENX's Times Interest Earned at -$0.24 in Q1 2026, -$1.53 in Q3 2025, and -$5896.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Tenax Therapeutics | 655.78 Mn | 655.78 Mn | - | -0.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.24 |
| Sep 30, 2025 | -1.53 |
| Jun 30, 2025 | -5,896.00 |
| Mar 31, 2025 | -5,939.24 |
| Dec 31, 2024 | 7,295.00 |
| Sep 30, 2024 | -659.86 |
| Jun 30, 2024 | -407.89 |
| Mar 31, 2024 | -488.63 |
| Dec 31, 2023 | -4,607.58 |
| Sep 30, 2023 | 131.60 |
| Jun 30, 2023 | 68.23 |
| Mar 31, 2023 | -44.78 |
| Sep 30, 2022 | 12.82 |
| Jun 30, 2022 | 11.02 |
| Mar 31, 2022 | 9.35 |
| Sep 30, 2021 | 10.76 |
| Jun 30, 2021 | 15.52 |
| Mar 31, 2021 | 762.33 |
| Dec 31, 2020 | 1,071.99 |
| Sep 30, 2020 | 24.13 |